• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NEDD8对pVHL的修饰是纤连蛋白基质组装和抑制肿瘤发展所必需的。

pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development.

作者信息

Stickle Natalie H, Chung Jacky, Klco Jeffery M, Hill Richard P, Kaelin William G, Ohh Michael

机构信息

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.

出版信息

Mol Cell Biol. 2004 Apr;24(8):3251-61. doi: 10.1128/MCB.24.8.3251-3261.2004.

DOI:10.1128/MCB.24.8.3251-3261.2004
PMID:15060148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC381603/
Abstract

Functional inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene is the cause of the familial VHL disease and most sporadic renal clear-cell carcinomas (RCC). pVHL has been shown to play a role in the destruction of hypoxia-inducible factor alpha (HIF-alpha) subunits via ubiquitin-mediated proteolysis and in the regulation of fibronectin matrix assembly. Although most disease-causing pVHL mutations hinder the regulation of the HIF pathway, every disease-causing pVHL mutant tested to date has failed to promote the assembly of the fibronectin matrix, underscoring its potential importance in VHL disease. Here, we report that a ubiquitin-like molecule called NEDD8 covalently modifies pVHL. A nonneddylateable pVHL mutant, while retaining its ability to ubiquitylate HIF, failed to bind to and promote the assembly of the fibronectin matrix. Expression of the neddylation-defective pVHL in RCC cells, while restoring the regulation of HIF, failed to promote the differentiated morphology in a three-dimensional growth assay and was insufficient to suppress the formation of tumors in SCID mice. These results suggest that NEDD8 modification of pVHL plays an important role in fibronectin matrix assembly and that in the absence of such regulation, an intact HIF pathway is insufficient to prevent VHL-associated tumorigenesis.

摘要

冯·希佩尔-林道(VHL)肿瘤抑制基因的功能失活是家族性VHL病和大多数散发性肾透明细胞癌(RCC)的病因。已证明pVHL通过泛素介导的蛋白水解作用参与缺氧诱导因子α(HIF-α)亚基的降解,并参与纤连蛋白基质组装的调节。尽管大多数致病的pVHL突变会阻碍HIF途径的调节,但迄今为止测试的每个致病pVHL突变体都未能促进纤连蛋白基质的组装,这突出了其在VHL病中的潜在重要性。在此,我们报告一种名为NEDD8的类泛素分子可共价修饰pVHL。一种不可被NEDD化的pVHL突变体,虽然保留了其泛素化HIF的能力,但未能结合并促进纤连蛋白基质的组装。在RCC细胞中表达缺乏NEDD化功能的pVHL,虽然恢复了对HIF的调节,但在三维生长试验中未能促进分化形态,并且不足以抑制SCID小鼠中的肿瘤形成。这些结果表明,pVHL的NEDD8修饰在纤连蛋白基质组装中起重要作用,并且在缺乏这种调节的情况下,完整的HIF途径不足以预防VHL相关的肿瘤发生。

相似文献

1
pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development.NEDD8对pVHL的修饰是纤连蛋白基质组装和抑制肿瘤发展所必需的。
Mol Cell Biol. 2004 Apr;24(8):3251-61. doi: 10.1128/MCB.24.8.3251-3261.2004.
2
Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.致病型pVHL突变对HIF-1α调控的不同影响与希佩尔-林道病的肿瘤发生模式相关。
Hum Mol Genet. 2001 May 1;10(10):1029-38. doi: 10.1093/hmg/10.10.1029.
3
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.与2C型VHL病相关的希佩尔-林道蛋白突变体保留了下调缺氧诱导因子的能力。
Hum Mol Genet. 2001 May 1;10(10):1019-27. doi: 10.1093/hmg/10.10.1019.
4
Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein.冯·希佩尔-林道肿瘤抑制蛋白外显子2编码的β结构域的作用
J Biol Chem. 2001 Jan 12;276(2):1407-16. doi: 10.1074/jbc.M008295200.
5
Identification of novel VHL target genes and relationship to hypoxic response pathways.新型VHL靶基因的鉴定及其与缺氧反应途径的关系。
Oncogene. 2005 Jun 30;24(28):4549-58. doi: 10.1038/sj.onc.1208649.
6
Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.肾癌中的冯·希佩尔-林道肿瘤抑制蛋白与缺氧诱导因子
Am J Nephrol. 2004 Jan-Feb;24(1):1-13. doi: 10.1159/000075346. Epub 2003 Dec 3.
7
In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.分析冯·希佩尔-林道病特异性突变的体外和体内模型。
Cancer Res. 2004 Dec 1;64(23):8595-603. doi: 10.1158/0008-5472.CAN-04-1430.
8
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.在肾癌细胞中,因冯·希佩尔-林道肿瘤抑制基因功能缺失,缺氧诱导因子HIF-1α和HIF-2α在常氧条件下上调。
Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938.
9
Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.纤连蛋白和缺氧诱导因子-1α在肾细胞癌中的表达:与冯·希佩尔-林道基因失活的关系
Cancer Genet Cytogenet. 2004 Jul 15;152(2):89-94. doi: 10.1016/j.cancergencyto.2003.11.001.
10
Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.通过表达阵列分析鉴定细胞周期蛋白D1和其他与希佩尔-林道肿瘤抑制基因相关的新靶点,并研究细胞周期蛋白D1基因型作为希佩尔-林道病的修饰因子。
Cancer Res. 2002 Jul 1;62(13):3803-11.

引用本文的文献

1
Inhibiting neddylation: A new strategy for tumor therapy.抑制NEDDylation:一种肿瘤治疗的新策略。
J Pharm Anal. 2025 May;15(5):101140. doi: 10.1016/j.jpha.2024.101140. Epub 2024 Nov 8.
2
Deciphering the roles of neddylation modification in hepatocellular carcinoma: Molecular mechanisms and targeted therapeutics.解读NEDDylation修饰在肝细胞癌中的作用:分子机制与靶向治疗
Genes Dis. 2024 Dec 6;12(4):101483. doi: 10.1016/j.gendis.2024.101483. eCollection 2025 Jul.
3
Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma.VHL介导的视网膜母细胞瘤蛋白(pRb)调控缺失促进肾透明细胞癌。
Cell Death Dis. 2025 Apr 16;16(1):307. doi: 10.1038/s41419-025-07623-y.
4
Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review).结直肠癌研究进展:揭示泛素化修饰的细胞和分子机制(综述)。
Int J Oncol. 2024 Apr;64(4). doi: 10.3892/ijo.2024.5627. Epub 2024 Feb 23.
5
Segregation of pathways leading to pexophagy.导致过氧化物酶体自噬途径的分离。
Life Sci Alliance. 2023 Feb 21;6(5). doi: 10.26508/lsa.202201825. Print 2023 May.
6
A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins-UBL3.泛素样蛋白 UBL3 或成为癌症治疗的新靶点
Int J Mol Sci. 2023 Jan 8;24(2):1231. doi: 10.3390/ijms24021231.
7
The Extracellular Matrix Environment of Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌的细胞外基质环境
Cancers (Basel). 2022 Aug 23;14(17):4072. doi: 10.3390/cancers14174072.
8
Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata.缺氧诱导因子是 von Hippel-Lindau 病特征的基础。
Elife. 2022 Aug 30;11:e80774. doi: 10.7554/eLife.80774.
9
VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions.VHL-P138R 和 VHL-L163R 新型变异体:涉及 HIF 依赖性和非依赖性作用的 VHL 致病性机制。
Front Endocrinol (Lausanne). 2022 Mar 21;13:854365. doi: 10.3389/fendo.2022.854365. eCollection 2022.
10
Emerging role of protein modification in inflammatory bowel disease.蛋白质修饰在炎症性肠病中的新作用。
J Zhejiang Univ Sci B. 2022 Mar 15;23(3):173-188. doi: 10.1631/jzus.B2100114.

本文引用的文献

1
VHL and kidney cancer.VHL与肾癌
Methods Mol Biol. 2003;222:167-83. doi: 10.1385/1-59259-328-3:167.
2
The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity.VHL蛋白招募一种新型KRAB-A结构域蛋白以抑制HIF-1α的转录活性。
EMBO J. 2003 Apr 15;22(8):1857-67. doi: 10.1093/emboj/cdg173.
3
Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex.人类HIF-3α基因座的多个剪接变体是冯·希佩尔-林道E3泛素连接酶复合物的作用靶点。
J Biol Chem. 2003 Mar 28;278(13):11032-40. doi: 10.1074/jbc.M208681200. Epub 2003 Jan 21.
4
Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.冯·希佩尔-林道肿瘤抑制蛋白pVHL对微管稳定性的调节
Nat Cell Biol. 2003 Jan;5(1):64-70. doi: 10.1038/ncb899.
5
Playing Tag with HIF: The VHL Story.与缺氧诱导因子玩捉迷藏:VHL基因的故事
J Biomed Biotechnol. 2002;2(3):131-135. doi: 10.1155/S1110724302205057.
6
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.作用于缺氧诱导因子的哺乳动物脯氨酰羟化酶的生化纯化及药理抑制
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13459-64. doi: 10.1073/pnas.192342099. Epub 2002 Sep 26.
7
The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1.冯·希佩尔-林道肿瘤抑制蛋白可稳定新型植物同源结构域蛋白Jade-1。
J Biol Chem. 2002 Oct 18;277(42):39887-98. doi: 10.1074/jbc.M205040200. Epub 2002 Aug 6.
8
An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells.完整的NEDD8途径是哺乳动物细胞中Cullin依赖性泛素化所必需的。
EMBO Rep. 2002 Feb;3(2):177-82. doi: 10.1093/embo-reports/kvf028. Epub 2002 Jan 29.
9
Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein.一种新型去泛素化酶的泛素化需要直接与冯·希佩尔-林道肿瘤抑制蛋白结合。
J Biol Chem. 2002 Feb 15;277(7):4656-62. doi: 10.1074/jbc.M108269200. Epub 2001 Dec 5.
10
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.秀丽隐杆线虫的EGL-9及其哺乳动物同源物定义了一个双加氧酶家族,该家族通过脯氨酰羟化作用调节缺氧诱导因子。
Cell. 2001 Oct 5;107(1):43-54. doi: 10.1016/s0092-8674(01)00507-4.